SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001140361-19-021903
Filing Date
2019-12-04
Accepted
2019-12-04 06:09:23
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 38477
2 nt10006280x3_img01.jpg GRAPHIC 28720
  Complete submission text file 0001140361-19-021903.txt   79186
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)